Magnoliamedical
Makes the Steripath blood culture collection device that reduces contamination for hospitals and health systems
Highlights
- New on EvolcAdded 2026-11-13
About Magnoliamedical
Magnolia Medical Technologies makes the Steripath Platform, centred on the Steripath Micro Initial Specimen Diversion Device, which is used in blood culture collection. The device diverts the initial 0.5 to 1.0 mL of blood into a separate chamber before the culture bottle is filled, and it is FDA 510(k)-cleared with an indication to reduce blood culture contamination.
Customers are hospitals and healthcare systems. The Steripath Micro is offered exclusively with BD Vacutainer UltraTouch push-button blood collection sets and is compatible with BD BACTEC and bioMérieux BACT/ALERT blood culture systems. The company offers a Clinical Performance Guarantee to reduce blood culture contamination rates at a hospital by at least 50%.
The company was co-founded by Gregory J. Bullington and Dr. Richard Patton, whose clinical study on initial specimen diversion was published in the Journal of Clinical Microbiology in 2010. It reports more than 100 issued patents and 70+ pending patent applications. Jason Richey is President and CEO. The company is currently hiring for sales roles and an engineering role.
Product: Steripath Micro Initial Specimen Diversion Device and the Steripath Platform for blood culture collection.
Jobs at Magnoliamedical
More health & medtech companies
Mamayahealth
Specialized mental health care for women across life stages, including therapy, psychiatric care and self-paced programsNew on EvolcMarathonhealth
Advanced primary care services for employers, labor groups, health plans, and their members across the United StatesSalary transparentMarisa Peer
Therapy, self-hypnosis programs, books and therapist training for people seeking personal change and practitioners learning RTTRemote-friendlySalary transparentMATTER
Chicago incubator supporting healthcare startups and helping health systems and life sciences firms source and co-develop innovationsNew on EvolcMedable
Clinical trial software and AI platform for pharmaceutical sponsors and contract research organizationsRemote-friendlyMedElite Group, LLC.
On-site clinical departments and specialist consultations for skilled nursing and long-term care facilities in the US
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Tag ManagerMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Forms
- Google reCAPTCHAHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Gravity FormsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Recruiting
- BambooHRMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.